Ultra-low-dose continuous combined estradiol and dydrogesterone in postmenopausal women: A pooled safety and tolerability analysis

• Váldodahkkit: Tetiana Tatarchuk (Dahkki), John C. Stevenson (Dahkki), Qi Yu (Dahkki), Elke Kahler (Dahkki), Marcelo Graziano Custodio (Dahkki), Mulan Ren (Dahkki), Rossella E. Nappi (Dahkki), Viktoriya Karpova (Dahkki), Tommaso Simoncini (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Objective: To assess the safety and tolerability of ultra-low dose estradiol and dydrogesterone (E0.5 mg/D2.5 mg) among postmenopausal women. Methods: This pooled analysis of data from three clinical studies assessed the effects of continuous combined ultra-low-dose estradiol and dydrogesterone amon...